Alis Ilie
Dijon, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Pooled analysis of 2 clinical trials of first-line chemoimmunotherapy for metastatic microsatellite stable colorectal cancer MEDITREME and METIMMOX studies.
Journal: Oncoimmunology
Published: June 20, 2026
Deep learning based on CD3 histological slides for prediction of colon cancer outcome: analysis of three international stage III colon cancer cohorts.
Journal: Oncoimmunology
Published: May 08, 2026
Corrigendum to "Combination of CDX2H-score quantitative analysis with CD3 AI-guided analysis identifies patients with a good prognosis only in stage III colon cancer" [In European Journal of Cancer, Volume 172, 2022, Pages 221-230, ISSN 0959-8049].
Journal: European journal of cancer (Oxford, England : 1990)
Published: April 07, 2026
Deep learning-based assessment of PD-L1 expression in NSCLC predicts outcome for patients treated with anti-PD-1 immunotherapy.
Journal: Frontiers in immunology
Published: November 20, 2025
Cancer cell-derived IL-1β reverses chemo-immunotherapy resistance in non-small cell lung cancer.
Journal: Nature communications
Published: May 13, 2025
Tumor-Associated Macrophages Produce PGE2 to Promote CD8+ T-cell Exhaustion and Drive Resistance to PD-L1 Blockade in Microsatellite-Stable Colorectal Cancer.
Journal: Cancer research
Published: January 07, 2025
Deep Multiple Instance Learning Model to Predict Outcome of Pancreatic Cancer Following Surgery.
Journal: Biomedicines
Published: September 30, 2024
Co-targeting TGF-β and PD-L1 sensitizes triple-negative breast cancer to experimental immunogenic cisplatin-eribulin chemotherapy doublet.
Journal: The Journal of clinical investigation
Published: July 05, 2024
Case report: Immune response characterization of a pseudoprogression in a PD-L1-negative, TMB-low, KEAP1/STK11 co-mutated metastatic NSCLC.
Journal: Frontiers in immunology
Published: May 24, 2024
CD3-CD8 immune score associated with a clinical score stratifies PDAC prognosis regardless of adjuvant or neoadjuvant chemotherapy.
Journal: Oncoimmunology
Published: January 03, 2024
Machine learning evaluation of immune infiltrate through digital tumour score allows prediction of survival outcome in a pooled analysis of three international stage III colon cancer cohorts.
Journal: EBioMedicine
Published: December 18, 2023
Pathologic and immunohistochemical prognostic markers in residual triple-negative breast cancer after neoadjuvant chemotherapy.
Journal: Frontiers in oncology
Published: October 08, 2023
Last Updated: 09/26/2026